Protagonist Therapeutics Inc sell StockNews.com
Start price
31.05.25
/
50%
€41.80
Target price
31.05.26
-
Performance (%)
65.07%
Price
12.01.26
€69.00
Summary
This prediction is currently active. The price for Protagonist Therapeutics Inc has massively increased, which is bad news for the SELL prediction by StockNews_com. This prediction currently runs until 31.05.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -4.167% | -4.167% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by StockNews_com for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
18.10.23
18.10.23
-
18.10.24
18.10.24
-
19.10.24
19.10.24
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
30.09.23
30.09.23
-
30.09.24
30.09.24
-
01.10.24
01.10.24